ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,041.98
-0.06%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. カナダ
  5. CSE
  6. Defence Therapeutics Inc (DTC)

  7. Defence Therapeutics Inc (DTC) ニュース

DTC

Defence Therapeutics (DTC)

Defence Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:CSE:DTC
日付受信時刻ニュースソース見出しコード企業名
2022/02/1700 : 00InvestorsHub NewsWireDEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCERCSE:DTCDefence Therapeutics Inc
2022/01/2622 : 49InvestorsHub NewsWireDefence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9CSE:DTCDefence Therapeutics Inc
2021/12/0102 : 32InvestorsHub NewsWireDEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENTCSE:DTCDefence Therapeutics Inc
2021/11/2322 : 24InvestorsHub NewsWireDEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCERCSE:DTCDefence Therapeutics Inc
2021/11/1001 : 50InvestorsHub NewsWireDEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORSCSE:DTCDefence Therapeutics Inc
2021/11/0321 : 11InvestorsHub NewsWireVACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITSCSE:DTCDefence Therapeutics Inc
2021/10/1322 : 15InvestorsHub NewsWireDEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCERCSE:DTCDefence Therapeutics Inc
2021/10/0622 : 32InvestorsHub NewsWireDEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMACSE:DTCDefence Therapeutics Inc
2021/09/2921 : 30InvestorsHub NewsWireDEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCERCSE:DTCDefence Therapeutics Inc
2021/09/2023 : 01InvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALSCSE:DTCDefence Therapeutics Inc
2021/09/1421 : 13InvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESS IN TESTING IT'S COVID-19 ACCUVAC-PT001 VACCINE IN A NON-RODENT MODELCSE:DTCDefence Therapeutics Inc
2021/09/0720 : 35InvestorsHub NewsWireDEFENCE THERAPEUTICS DEVELOPMENT PROGRAM TO ENGINEER A NEW HPV VACCINE INITIATEDCSE:DTCDefence Therapeutics Inc
2021/09/0123 : 39InvestorsHub NewsWireThe vaccination specialist is about to become popularCSE:DTCDefence Therapeutics Inc
 Showing the most relevant articles for your search:CSE:DTC

最近閲覧した銘柄

BIT
BIEAXA
Bioera
ASX
DMPKOD
KRKN
COTIUSD
COTI
TSXV
SLC
SLYCE Inc.
TSXV
MNS
IDCM
SWMBTC
Swarm
EU
CDCFT
Caisse Depots et Consign...
EU
M835S
M835S
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有